RecruitingNot applicableNCT07021495
SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)
Studying Primary cutaneous T-cell lymphoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Leiden University Medical Center
- Principal Investigator
- Robert Rissmann, Professor
- Enrollment
- 840 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2029
Study locations (8)
- Radboud University Medical Center, Nijmegen, Gelderland, Netherlands
- Maastricht University Medical Center+, Maastricht, Limburg, Netherlands
- Amsterdam University Medical Center, Amsterdam, North Holland, Netherlands
- University Medical Center Groningen, Groningen, Provincie Groningen, Netherlands
- Leiden University Medical Center, Leiden, South Holland, Netherlands
- Centre for Human Drug Research, Leiden, South Holland, Netherlands
- Erasmus Medical Center, Rotterdam, South Holland, Netherlands
- University Medical Center Utrecht, Utrecht, Utrecht, Netherlands
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07021495 on ClinicalTrials.gov